Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 161 participants.

Also called NCT02391337

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 161 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02391337
Other papers using this trial's data
  • Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial Nature medicine, 2024-07 DOI, PubMed 39009776, PMC11271403 In the PMC Open Access subset under CC BY.
  • Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial Heart (British Cardiac Society), 2025-03-26 DOI, PubMed 39819610, PMC12015011 In the PMC Open Access subset under CC BY.
  • Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial JAMA, 2020-12-22 DOI, PubMed 33351042, PMC7756234 Not in the PMC Open Access subset.
  • Quantification and impact of circulating cardiotonic steroids in the RATE-AF randomised trial of patients with atrial fibrillation and heart failure BMC medicine, 2025-12-29 DOI, PubMed 41462450, PMC12751528 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02391337. Randomized; no masking; primary purpose treatment. Start 2016-12-20 (actual); primary completion 2019-04-15 (actual). Results posted on 2021-06-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Acronym
RATE-AF
Condition
Permanent Atrial Fibrillation
Intervention (Drug)
Bisoprolol
Intervention (Drug)
Digoxin
Lead sponsor
University of Birmingham (class: other)

Record details

Record id
cardio:ct-nct02391337
Content hash
c7f0980a8ed1f1b1615b3f2974b8b467113392efbedae63ed37ad145e8c62dc8